Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMMUCELL CORP /DE/ Director's Dealing 2007

Apr 25, 2007

34519_dirs_2007-04-25_683c064e-019f-48a1-a451-ffbea47817fa.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2007-04-23

Reporting Person: ROTHSCHILD JONATHAN E (Director, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2007-04-23 Common Stock, par value $0.10 per share P 642 $5.36 Acquired 388102 Direct
2007-04-23 Common Stock, par value $0.10 per share P 400 $5.40 Acquired 388502 Direct
2007-04-24 Common Stock, par value $0.10 per share P 715 $5.36 Acquired 389217 Direct
2007-04-24 Common Stock, par value $0.10 per share P 300 $5.44 Acquired 389517 Direct
2007-04-24 Common Stock, par value $0.10 per share P 300 $5.45 Acquired 389817 Direct

Footnotes

F1: This figure includes 195,800 shares of common stock held by Arterio, Inc., a corporation owned solely by Mr. Rothschild.